FILE:STJ/STJ-8K-20060913093526.txt.gz
EVENTS:	Regulation FD Disclosure
TEXT:
ITEM: Regulation FD Disclosure
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
Item 7.01 Regulation FD Disclosure.
 
On September 12, 2006 at the Bear Stearns 19th Annual Healthcare Conference in New York City, New York, St. Jude Medical, Inc. stated that it continues to expect third-quarter revenue for implantable cardioverter defibrillator heart devices to be in the $265 million to $295 million range provided at the time of its earnings release for the second quarter of this year.
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 


